Showing results (51-60 of 896) with videos related to

Sort By:
Pageof 90
Clinical Calcium|December 27, 2013
[Updates of denosumab, anti-RANKL antibody for osteoporosis]Naoto Tokuyama, Sakae Tanaka
Clinical Calcium|July 27, 2017
[New methods for the evaluation of bone quality. Bone quality evaluation by QCT.]Satoru Ohashi, Sakae Tanaka
Arthritis Research & Therapy|May 17, 2017
Molecular mechanisms underlying osteoarthritis development: Notch and NF-κBTaku Saito, Sakae Tanaka
The Journal of Clinical Investigation|September 23, 2009
NF-kappaB2 (p100) limits TNF-alpha-induced osteoclastogenesisSakae Tanaka, Hiroyasu Nakano
Journal of Bone and Mineral Metabolism|October 18, 2020
RANKL as a therapeutic target of rheumatoid arthritisSakae Tanaka, Yoshiya Tanaka
Journal of Bone and Mineral Metabolism|November 18, 2020
Sclerostin: from bench to bedsideSakae Tanaka, Toshio Matsumoto
Archivum Immunologiae Et Therapiae Experimentalis|June 3, 2011
Bim: guardian of tissue homeostasis and critical regulator of the immune system, tumorigenesis and bone biologyToru Akiyama, Sakae Tanaka
Clinical Calcium|December 29, 2010
[Odanacatib (MK-0822)]Yuichi Nagase, Sakae Tanaka
Clinical Calcium|May 30, 2014
[Biological therapy for osteoporosis]Shinya Nakamura, Sakae Tanaka
Pageof 90